Skip to main content
CDC Website

Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional)

The objective of this Notice of Funding Opportunity (NOFO) is to support the continued development of new and innovative on-demand, event-driven, and long-acting (systemic and non-systemic) multipurpose prevention technologies (MPTs). It supports development of MPTs that prevent HIV infection and pregnancy (hormonal and non-hormonal methods); sexually transmitted infections (STI) and pregnancy; or multiple non-HIV STI or HIV/STI MPTs in cis and trans males and females of all ages. Applications for MPT development may involve pharmacokinetic (PK), pharmacodynamic (PD), safety and, drug-drug interactions (DDI) studies using drug development, and formulation science supported by animal model testing. Also supported are biobehavioral and behavioral/social studies to identify MPT user-desired rheological and biophysical factors (look, feel, effectiveness, safety, and duration of action) and other behavioral/social factors that could promote increased MPT adoption and use. 

Funding ID:
PAR-23-180
Application Due Date:
Application Contact
James
E
Cummins, Jr., Ph.D
Scientific/ Research Contact- NIAID
240-292-4800
cumminsje@niaid.nih.gov
Technical Contact
Ann
Devine
United States
240-669-2988
adevine@niaid.nih.gov
  • HIV/AIDS
  • Other Health-Related
  • STD
  • International
  • Clinical Research
  • Data Analysis
  • HIV
  • HIV and AIDS Prevention
  • Medical Treatments and Therapies
  • Research
  • STD/STI Prevention
Was this page helpful? Give Feedback